Publication Name	World Journal of Clinical Cases
Manuscript ID	85027
Country	China

Received	2023-04-08 13:25
Peer-Review Started	2023-04-08 13:27
To Make the First Decision
Return for Revision	2023-05-31 08:35
Revised	2023-06-05 13:33
Second Decision	2023-06-27 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-06-27 08:56
Articles in Press	2023-06-27 08:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-14 08:57
Publish the Manuscript Online	2023-07-27 01:26

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Primary ovarian angiosarcoma: Two case reports and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Ying Zhou, Yi-Wen Sun, Xiao-Yang Liu and Dan-Hua Shen
Funding Agency and Grant Number
Corresponding Author	Dan-Hua Shen, Doctor, Chief Physician, Department of Pathology, Peking University People’s Hospital, No. 11 Xizhimen South Street, Beijing 100044, China. shendanhua@pkuph.edu.cn
Key Words	Primary angiosarcoma; Ovarian; Therapy; Diagnosis; Prognosis; Case report
Core Tip	Angiosarcoma (AS) is a rare and highly aggressive type of soft tissue that most commonly arises in deep soft tissues. Alternative therapeutic strategies such as targeted therapies and anti-programmed cell death 1/programmed cell death ligand 1 therapy may be promising for primary ovarian AS.
Publish Date	2023-07-27 01:26
Citation	Zhou Y, Sun YW, Liu XY, Shen DH. Primary ovarian angiosarcoma: Two case reports and review of literature. World J Clin Cases 2023; 11(21): 5122-5128
URL	https://www.wjgnet.com/2307-8960/full/v11/i21/5122.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i21.5122

Full Article (PDF)	WJCC-11-5122-with-cover.pdf
Full Article (Word)	WJCC-11-5122.docx
CARE Checklist–2016	85027-CARE-Checklist–2016-revision.pdf
Manuscript File	85027_Auto_Edited-JLW.docx
Answering Reviewers	85027-Answering reviewers.pdf
Audio Core Tip	85027-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	85027-Conflict-of-interest statement.pdf
Copyright License Agreement	85027-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	85027-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	85027-Language certificate.pdf
Peer-review Report	85027-Peer-review(s).pdf
Scientific Misconduct Check	85027-Bing-Wang JJ-2.png
Scientific Editor Work List	85027-Scientific editor work list.pdf